Company / Cash & Equivalents
iRhythm Holdings, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$236.0M
FY2025
5-year range
$36.2M / $419.6M
FY2021-FY2025
Trend
-43.8%
vs FY2024
Sector context
#76 of 152
Health Care
What the data says
At $236M, iRhythm Holdings, Inc.'s cash & equivalents ranks #76 of 152 in the Health Care sector. Cash & Equivalents has fluctuated over the past 10 years, ranging from $9M in FY2017 to $420M in FY2024.
Based on SEC 10-K filings.
$236M in FY2025 with a 5-year CAGR of +21.6%.
Improved from $36M to $236M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +44.1%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Sector benchmark
#76 of 152 in Health CareTop 50% of 152This company $236.0M Sector average $1.2B
▼
-79.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.6%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 43.8% year-over-year.
- Ranks #76 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $236.0M | -43.8% |
| FY2024 | $419.6M | +1060.0% |
| FY2023 | $36.2M | -54.1% |
| FY2022 | $78.8M | -38.2% |
| FY2021 | $127.6M | +43.9% |
| FY2020 | $88.6M | +333.1% |
| FY2019 | $20.5M | +2.2% |
| FY2018 | $20.0M | +130.9% |
| FY2017 | $8.7M | -83.2% |
| FY2016 | $51.6M | +104.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026